SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599901-24-000002
Filing Date
2024-01-05
Accepted
2024-01-05 08:36:20
Documents
12
Period of Report
2023-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rna-20231231.htm   iXBRL 8-K 35888
  Complete submission text file 0001599901-24-000002.txt   167404

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20231231.xsd EX-101.SCH 1931
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20231231_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20231231_pre.xml EX-101.PRE 13067
6 EXTRACTED XBRL INSTANCE DOCUMENT rna-20231231_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 24514511
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)